Deep Learning-Based Synthetic CT for Low Field Brain MR-Guided Radiation Therapy.
Yan Y, Kim JP, Nejad-Davarani SP, Dong M, Hurst NJ Jr, Zhao J, Glide-Hurst CK.Int J Radiat Oncol Biol Phys. 2024 Sep 30:S0360-3016(24)03445-X. doi: 10.1016/j.ijrobp.2024.09.046. Online ahead of print.PMID: 39357787
Ensuring High Quality Treatment Plans with a Plan Quality Review Checklist.
Lin MH, Olsen L, Kavanaugh JA, Jacqmin D, Lobb E, Yoo S, Berry SL, Pichardo JC, Cardenas CE, Roper J, Kirk M, Bennett S, Cheung JP, Solberg TD, Moore KL, Kim M.Pract Radiat Oncol. 2024 Sep 30:S1879-8500(24)00218-2. doi: 10.1016/j.prro.2024.08.008. Online ahead of print.PMID: 39357772
The Potential and Challenges of Proton FLASH in Head and Neck Cancer Reirradiation.
Cheng C, Xu L, Jing H, Selvaraj B, Lin H, Pennock M, Chhabra AM, Hasan S, Zhai H, Zhang Y, Nie K, Bakst RL, Kabarriti R, Choi JI, Lee NY, Simone CB 2nd, Kang M, Wu H.Cancers (Basel). 2024 Sep 24;16(19):3249. doi: 10.3390/cancers16193249.PMID: 39409872
Clinical cell-surface targets in metastatic and primary solid cancers.
Sharifi MN, Shi Y, Chrostek MR, Callahan SC, Shang T, Berg TJ, Helzer KT, Bootsma ML, Sjöström M, Josefsson A, Feng FY, Huffman LB, Schulte C, Blitzer GC, Sodji QH, Morris ZS, Ma VT, Meimetis L, Kosoff D, Taylor AK, LeBeau AM, Lang JM, Zhao SG.JCI Insight. 2024 Sep 24;9(18):e183674. doi: 10.1172/jci.insight.183674.PMID: 39315546
Chromosomal instability increases radiation sensitivity.
Cosper PF, Paracha M, Jones KM, Hrycyniak L, Henderson L, Bryan A, Eyzaguirre D, McCunn E, Boulanger E, Wan J, Nickel KP, Horner V, Hu R, Harari PM, Kimple RJ, Weaver BA.bioRxiv [Preprint]. 2024 Sep 19:2024.09.13.612942. doi: 10.1101/2024.09.13.612942.PMID: 39345631
Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade.
Jagodinsky JC, Vera JM, Jin WJ, Shea AG, Clark PA, Sriramaneni RN, Havighurst TC, Chakravarthy I, Allawi RH, Kim K, Harari PM, Sondel PM, Newton MA, Crittenden MR, Gough MJ, Miller JR, Ong IM, Morris ZS.Sci Transl Med. 2024 Sep 18;16(765):eadk0642. doi: 10.1126/scitranslmed.adk0642. Epub 2024 Sep 18.PMID: 39292804
GABA(A) Receptor Activation Drives GABARAP-Nix Mediated Autophagy to Radiation-Sensitize Primary and Brain-Metastatic Lung Adenocarcinoma Tumors.
Bhattacharya D, Barrile R, Toukam DK, Gawali VS, Kallay L, Ahmed T, Brown H, Rezvanian S, Karve A, Desai PB, Medvedovic M, Wang K, Ionascu D, Harun N, Vallabhapurapu S, Wang C, Qi X, Baschnagel AM, Kritzer JA, Cook JM, Pomeranz Krummel DA, Sengupta S.Cancers (Basel). 2024 Sep 15;16(18):3167. doi: 10.3390/cancers16183167.PMID: 39335139
Targeted inhibition of BET proteins in HPV16-positive head and neck squamous cell carcinoma reveals heterogeneous transcriptional responses.
Rao A, Stosic MS, Mohanty C, Suresh D, Wang AR, Lee DL, Nickel KP, Chandrashekar DS, Kimple RJ, Lambert PF, Kendziorski C, Rounge TB, Iyer G.Front Oncol. 2024 Sep 5;14:1440836. doi: 10.3389/fonc.2024.1440836. eCollection 2024.PMID: 39301555
Carboplatin and Paclitaxel Chemoradiation for Localized Anal Cancer in Patients Not Eligible for Mitomycin and 5-Fluorouracil.
DeZeeuw AK, Bassetti MF, Carchman EH, Heise CP, Hayden D, Lawson EH, Sanger CB, King R, LoConte NK, Lubner SJ, Kratz JD, Deming DA.Cancers (Basel). 2024 Sep 3;16(17):3062. doi: 10.3390/cancers16173062.PMID: 39272920
Cancer therapy-related salivary dysfunction.
Paz C, Glassey A, Frick A, Sattar S, Zaorsky NG, Blitzer GC, Kimple RJ.J Clin Invest. 2024 Sep 3;134(17):e182661. doi: 10.1172/JCI182661.PMID: 39225092
Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline.
Margalit DN, Anker CJ, Aristophanous M, Awan M, Bajaj GK, Bradfield L, Califano J, Caudell JJ, Chapman CH, Garden AS, Harari PM, Helms A, Lin A, Maghami E, Mehra R, Parker L, Shnayder Y, Spencer S, Swiecicki PL, Tsai JC, Sher DJ.Pract Radiat Oncol. 2024 Sep-Oct;14(5):398-425. doi: 10.1016/j.prro.2024.05.007. Epub 2024 Jun 18.PMID: 39078350
Patient-specific quality assurance of dynamically-collimated proton therapy treatment plans.
Bennett LC, Hyer DE, Vu J, Patwardhan K, Erhart K, Gutierrez AN, Pons E, Jensen E, Ubau M, Zapata J, Wroe A, Wake K, Nelson NP, Culberson WS, Smith BR, Hill PM, Flynn RT.Med Phys. 2024 Sep;51(9):5901-5910. doi: 10.1002/mp.17295. Epub 2024 Jul 8.PMID: 38977285
Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer.
Minne RL, Luo NY, Traynor AM, Huang M, DeTullio L, Godden J, Stoppler M, Kimple RJ, Baschnagel AM.Clin Lung Cancer. 2024 Sep;25(6):567-576.e1. doi: 10.1016/j.cllc.2024.05.001. Epub 2024 May 10.PMID: 38852006
Technical note: Characterization of a multi-point scintillation dosimetry research platform for a low-field MR-Linac.
Crosby J, Ruff C, Gregg K, Turcotte J, Glide-Hurst C.Med Phys. 2024 Sep;51(9):6475-6484. doi: 10.1002/mp.17192. Epub 2024 Jun 6.PMID: 38843532
Repeat it without me: Crowdsourcing the T1 mapping common ground via the ISMRM reproducibility challenge.
Boudreau M, Karakuzu A, Cohen-Adad J, Bozkurt E, Carr M, Castellaro M, Concha L, Doneva M, Dual SA, Ensworth A, Foias A, Fortier V, Gabr RE, Gilbert G, Glide-Hurst CK, Grech-Sollars M, Hu S, Jalnefjord O, Jovicich J, Keskin K, Koken P, Kolokotronis A, Kukran S, Lee NG, Levesque IR, Li B, Ma D, Mädler B, Maforo NG, Near J, Pasaye E, Ramirez-Manzanares A, Statton B, Stehning C, Tambalo S, Tian Y, Wang C, Weiss K, Zakariaei N, Zhang S, Zhao Z, Stikov N; ISMRM Reproducible Research Study Group and the ISMRM Quantitative MR Study Group.Magn Reson Med. 2024 Sep;92(3):1115-1127. doi: 10.1002/mrm.30111. Epub 2024 May 10.PMID: 38730562